Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
NC elections upended by Helene: Voting could be delayed, ballots might be lost. Here's what you need to know
Recommended
PCBs at NC State: Dorms, library, classroom buildings test positive
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Monopar Therapeutics Inc
(NQ:
MNPR
)
5.500
+0.330 (+6.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
160,203
Open
5.560
Bid (Size)
5.310 (1)
Ask (Size)
5.690 (2)
Prev. Close
5.170
Today's Range
5.029 - 5.730
52wk Range
1.369 - 8.650
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Monopar Initiates Clinical Trial of Novel uPAR-Targeted Radiopharmaceutical Therapy in Advanced Cancers
October 07, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 01, 2024
Via
Benzinga
Performance
YTD
+197.30%
+197.30%
1 Month
+129.17%
+129.17%
3 Month
+54.56%
+54.56%
6 Month
+40.85%
+40.85%
1 Year
+138.61%
+138.61%
More News
Read More
Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today
September 12, 2024
Via
Benzinga
Monopar Announces Positive Early Human Clinical Data Validating the Tumor Targeting Ability of MNPR-101-Zr
September 12, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
August 27, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in Advanced Cancers
August 21, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR-101-Zr
August 14, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
MNPR Stock Earnings: Monopar Therapeutics Misses EPS for Q2 2024
August 09, 2024
Via
InvestorPlace
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
August 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics Announces 1-for-5 Reverse Stock Split
August 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmaceutical MNPR-101-Zr
July 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
June 25, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
June 24, 2024
Via
Benzinga
Monopar and NorthStar Amend & Extend Collaboration
June 11, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
June 10, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 07, 2024
Via
Benzinga
Penny Stocks That Insiders Are Loading Up On: 3 Names to Watch Closely
June 05, 2024
Via
InvestorPlace
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying
June 03, 2024
Via
Benzinga
Monopar Announces CFO Succession
May 24, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
MNPR Stock Earnings: Monopar Therapeutics Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
May 09, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
May 03, 2024
Via
Benzinga
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
April 18, 2024
From
Monopar Therapeutics Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.